Europe Transcatheter Heart Valve Market Analysed and Forecast in Topical GBI Research Report Published at MarketPublishers.com

Topical study “Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)” drawn up by GBI Research is now available at MarketPublishers.com

London, UK (PRWEB) October 23, 2014

The European transcatheter heart valve (THV) market value is expected to grow from a value of around USD 483 million as of 2013 to reach close to USD 1.66 billion by 2020-end, at a CAGR of nearly 19.5%. This colossal growth, relating to the five leading markets of Germany, Italy, France, the UK and Spain, is likely to follow a boom that witnessed the market skyrocket from USD 9.2 million in 2007 to USD 482.8 million as of 2013, at an exclusive CAGR of just under 93.5%.

Germany is the leading country market for THVs in Europe, with its share expected to be estimated at USD 827 million by 2020, representing nearly half the overall value of the market. The increased approval of transcatheter aortic valve replacement (TAVR) procedures for high-risk patient groups fuelled such a skyrocketing growth during the review period. Germany was the first to adopt TAVR procedures, with its large number of high-risk and inoperable patients creating high demand and hence driving the market's expansion.

Topical study “Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)” drawn up by GBI Research is now available at MarketPublishers.com

Report Details:

Title: Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)
Published: August, 2014
Pages: 27
Price: US$ 1,750.00
http://marketpublishers.com/report/diagnostics-diseases/cardiovascular/market-snapshot-transcatheter-heart-valve-2007-to-2020-europe.html

The research publication provides a detailed quantitative assessment of the European market for transcatheter heart valves. It presents annualised sales data on market size by volume and revenue during2007–2013 plus forecasts to 2020 as well as data on the leading companies' shares by revenue for 2013 for the countries like Germany, Italy, France, Spain and the UK.

Reasons to Buy:

• Gain actionable insights from volume-value relationships.
• Get wind of volume-value relationships and provide direction to marketing and sales strategies
• Devise and implement strategies for entering the market and expanding your share.
• Identify the key players best placed to benefit from the manifold opportunities in the European transcatheter heart valves market.

More topical reports by the publisher can be found at GBI Research page.

For the original version on PRWeb visit: http://www.prweb.com/releases/2014/10/prweb12269187.htm